Pacific Biosciences of California (PACB) ended the recent trading session at $1.22, demonstrating a +1.67% swing from the preceding day's closing price. The stock's change was less than the S&P ...

MENLO PARK, CA – Pacific Biosciences of California ... The agreement, effective from March 7, 2025, with Menlo Park Portfolio II, LLC, includes a rent abatement and tenant improvement allowance.

Pacific Biosciences of California has a 52 week low of $1.16 and a 52 week high of $4.10. The stock’s 50-day moving average price is $1.60 and its 200-day moving average price is $1.78.

Dupilumab vs placebo was linked to improved health-related quality of life and respiratory symptoms in patients with COPD and T2 inflammation.

80 years ago, American and Japanese troops were locked in one of the fiercest and bloodiest battles of the Pacific theatre in World War II: the Battle of Iwo Jima. The small island between the ...

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics ...

MENLO PARK, CA – Pacific Biosciences of California ... The agreement, effective from March 7, 2025, with Menlo Park Portfolio II, LLC, includes a rent abatement and tenant improvement allowance. The ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

At close: March 17 at 3:58:59 PM EDT Loading Chart for IFNNY ...

The Wall Street entrance to the New York Stock Exchange (NYSE) is seen in New York City, U.S., November 15, 2022. REUTERS/Brendan McDermid/File Photo ...